Madeline Gough

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West et al. · Blood · 2019 · 62 citations · Full text

Life Sciences, Immunology, Oncology +12

GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids

Nathalie Bock, Farzaneh Forouz, Luke Hipwood et al. · Pharmaceutics · 2023 · 56 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma

Thomas Kryza, Tashbib Khan, Simon Puttick et al. · Theranostics · 2020 · 32 citations · Full text

Medicine, Cell Biology, Oncology +17

The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer

Romain Tropée, Bárbara de la Peña Avalos, Madeline Gough et al. · Breast Cancer Research and Treatment · 2020 · 28 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy

Tashbib Khan, Nicholas Lyons, Madeline Gough et al. · Theranostics · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17